The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nuclear Medicine Imaging Agents Market Research Report 2024

Global Nuclear Medicine Imaging Agents Market Research Report 2024

Publishing Date : Jul, 2023

License Type :

Report Code : 1763575

No of Pages : 92

Ask Your Query

Report Description
Table of Content

Synopsis
Global Nuclear Medicine Imaging Agents market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nuclear Medicine Imaging Agents market research.

Key manufacturers engaged in the Nuclear Medicine Imaging Agents industry include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health and Blue Earth Diagnostics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Nuclear Medicine Imaging Agents were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nuclear Medicine Imaging Agents market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Imaging Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

GE HealthCare
Bracco Diagnostic
Guerbet
Mallinckrodt
Lantheus
Yantai Dongcheng
Foshan Rui Diao Pharmaceutical
Cardinal Health
Blue Earth Diagnostics
Bayer AG
Abx Advanced Biochemical
Eli Lilly and Company
Jubilant Pharma Limited
Navidea

Segment by Type

Fluorine 18 Labeling
Carbon 11 Labeling
Nitrogen 13 Labeling
Oxygen 15 Labeling
Technetium 99 Labeling
Others

Segment by Application

Early Diagnosis
Clinical Stage
Treatment Evaluation

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Nuclear Medicine Imaging Agents report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Nuclear Medicine Imaging Agents Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Imaging Agents
1.2 Nuclear Medicine Imaging Agents Segment by Type
1.2.1 Global Nuclear Medicine Imaging Agents Market Value Comparison by Type (2023-2029)
1.2.2 Fluorine 18 Labeling
1.2.3 Carbon 11 Labeling
1.2.4 Nitrogen 13 Labeling
1.2.5 Oxygen 15 Labeling
1.2.6 Technetium 99 Labeling
1.2.7 Others
1.3 Nuclear Medicine Imaging Agents Segment by Application
1.3.1 Global Nuclear Medicine Imaging Agents Market Value by Application: (2023-2029)
1.3.2 Early Diagnosis
1.3.3 Clinical Stage
1.3.4 Treatment Evaluation
1.4 Global Nuclear Medicine Imaging Agents Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine Imaging Agents Revenue 2018-2029
1.4.2 Global Nuclear Medicine Imaging Agents Sales 2018-2029
1.4.3 Global Nuclear Medicine Imaging Agents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nuclear Medicine Imaging Agents Market Competition by Manufacturers
2.1 Global Nuclear Medicine Imaging Agents Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nuclear Medicine Imaging Agents Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nuclear Medicine Imaging Agents Average Price by Manufacturers (2018-2023)
2.4 Global Nuclear Medicine Imaging Agents Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nuclear Medicine Imaging Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine Imaging Agents, Product Type & Application
2.7 Nuclear Medicine Imaging Agents Market Competitive Situation and Trends
2.7.1 Nuclear Medicine Imaging Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nuclear Medicine Imaging Agents Players Market Share by Revenue
2.7.3 Global Nuclear Medicine Imaging Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Medicine Imaging Agents Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine Imaging Agents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nuclear Medicine Imaging Agents Global Nuclear Medicine Imaging Agents Sales by Region: 2018-2029
3.2.1 Global Nuclear Medicine Imaging Agents Sales by Region: 2018-2023
3.2.2 Global Nuclear Medicine Imaging Agents Sales by Region: 2024-2029
3.3 Global Nuclear Medicine Imaging Agents Global Nuclear Medicine Imaging Agents Revenue by Region: 2018-2029
3.3.1 Global Nuclear Medicine Imaging Agents Revenue by Region: 2018-2023
3.3.2 Global Nuclear Medicine Imaging Agents Revenue by Region: 2024-2029
3.4 North America Nuclear Medicine Imaging Agents Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine Imaging Agents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nuclear Medicine Imaging Agents Sales by Country (2018-2029)
3.4.3 North America Nuclear Medicine Imaging Agents Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nuclear Medicine Imaging Agents Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine Imaging Agents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nuclear Medicine Imaging Agents Sales by Country (2018-2029)
3.5.3 Europe Nuclear Medicine Imaging Agents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medicine Imaging Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Nuclear Medicine Imaging Agents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nuclear Medicine Imaging Agents Sales by Country (2018-2029)
3.6.3 Asia Pacific Nuclear Medicine Imaging Agents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nuclear Medicine Imaging Agents Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine Imaging Agents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nuclear Medicine Imaging Agents Sales by Country (2018-2029)
3.7.3 Latin America Nuclear Medicine Imaging Agents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nuclear Medicine Imaging Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine Imaging Agents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nuclear Medicine Imaging Agents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nuclear Medicine Imaging Agents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Medicine Imaging Agents Sales by Type (2018-2029)
4.1.1 Global Nuclear Medicine Imaging Agents Sales by Type (2018-2023)
4.1.2 Global Nuclear Medicine Imaging Agents Sales by Type (2024-2029)
4.1.3 Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2018-2029)
4.2 Global Nuclear Medicine Imaging Agents Revenue by Type (2018-2029)
4.2.1 Global Nuclear Medicine Imaging Agents Revenue by Type (2018-2023)
4.2.2 Global Nuclear Medicine Imaging Agents Revenue by Type (2024-2029)
4.2.3 Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2018-2029)
4.3 Global Nuclear Medicine Imaging Agents Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nuclear Medicine Imaging Agents Sales by Application (2018-2029)
5.1.1 Global Nuclear Medicine Imaging Agents Sales by Application (2018-2023)
5.1.2 Global Nuclear Medicine Imaging Agents Sales by Application (2024-2029)
5.1.3 Global Nuclear Medicine Imaging Agents Sales Market Share by Application (2018-2029)
5.2 Global Nuclear Medicine Imaging Agents Revenue by Application (2018-2029)
5.2.1 Global Nuclear Medicine Imaging Agents Revenue by Application (2018-2023)
5.2.2 Global Nuclear Medicine Imaging Agents Revenue by Application (2024-2029)
5.2.3 Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2018-2029)
5.3 Global Nuclear Medicine Imaging Agents Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE HealthCare
6.1.1 GE HealthCare Corporation Information
6.1.2 GE HealthCare Description and Business Overview
6.1.3 GE HealthCare Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE HealthCare Nuclear Medicine Imaging Agents Product Portfolio
6.1.5 GE HealthCare Recent Developments/Updates
6.2 Bracco Diagnostic
6.2.1 Bracco Diagnostic Corporation Information
6.2.2 Bracco Diagnostic Description and Business Overview
6.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolio
6.2.5 Bracco Diagnostic Recent Developments/Updates
6.3 Guerbet
6.3.1 Guerbet Corporation Information
6.3.2 Guerbet Description and Business Overview
6.3.3 Guerbet Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Guerbet Nuclear Medicine Imaging Agents Product Portfolio
6.3.5 Guerbet Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Corporation Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Lantheus
6.5.1 Lantheus Corporation Information
6.5.2 Lantheus Description and Business Overview
6.5.3 Lantheus Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lantheus Nuclear Medicine Imaging Agents Product Portfolio
6.5.5 Lantheus Recent Developments/Updates
6.6 Yantai Dongcheng
6.6.1 Yantai Dongcheng Corporation Information
6.6.2 Yantai Dongcheng Description and Business Overview
6.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolio
6.6.5 Yantai Dongcheng Recent Developments/Updates
6.7 Foshan Rui Diao Pharmaceutical
6.6.1 Foshan Rui Diao Pharmaceutical Corporation Information
6.6.2 Foshan Rui Diao Pharmaceutical Description and Business Overview
6.6.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolio
6.7.5 Foshan Rui Diao Pharmaceutical Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Corporation Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cardinal Health Nuclear Medicine Imaging Agents Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 Blue Earth Diagnostics
6.9.1 Blue Earth Diagnostics Corporation Information
6.9.2 Blue Earth Diagnostics Description and Business Overview
6.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolio
6.9.5 Blue Earth Diagnostics Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Corporation Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bayer AG Nuclear Medicine Imaging Agents Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 Abx Advanced Biochemical
6.11.1 Abx Advanced Biochemical Corporation Information
6.11.2 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Description and Business Overview
6.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolio
6.11.5 Abx Advanced Biochemical Recent Developments/Updates
6.12 Eli Lilly and Company
6.12.1 Eli Lilly and Company Corporation Information
6.12.2 Eli Lilly and Company Nuclear Medicine Imaging Agents Description and Business Overview
6.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolio
6.12.5 Eli Lilly and Company Recent Developments/Updates
6.13 Jubilant Pharma Limited
6.13.1 Jubilant Pharma Limited Corporation Information
6.13.2 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Description and Business Overview
6.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolio
6.13.5 Jubilant Pharma Limited Recent Developments/Updates
6.14 Navidea
6.14.1 Navidea Corporation Information
6.14.2 Navidea Nuclear Medicine Imaging Agents Description and Business Overview
6.14.3 Navidea Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Navidea Nuclear Medicine Imaging Agents Product Portfolio
6.14.5 Navidea Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine Imaging Agents Industry Chain Analysis
7.2 Nuclear Medicine Imaging Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine Imaging Agents Production Mode & Process
7.4 Nuclear Medicine Imaging Agents Sales and Marketing
7.4.1 Nuclear Medicine Imaging Agents Sales Channels
7.4.2 Nuclear Medicine Imaging Agents Distributors
7.5 Nuclear Medicine Imaging Agents Customers
8 Nuclear Medicine Imaging Agents Market Dynamics
8.1 Nuclear Medicine Imaging Agents Industry Trends
8.2 Nuclear Medicine Imaging Agents Market Drivers
8.3 Nuclear Medicine Imaging Agents Market Challenges
8.4 Nuclear Medicine Imaging Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}